(NASDAQ: RNLX) Renalytix's forecast annual revenue growth rate of 86.72% is forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 13.35%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.2%.
Renalytix's revenue in 2024 is $2,410,000.On average, 1 Wall Street analysts forecast RNLX's revenue for 2024 to be $449,685,702, with the lowest RNLX revenue forecast at $449,685,702, and the highest RNLX revenue forecast at $449,685,702.
In 2025, RNLX is forecast to generate $1,498,952,340 in revenue, with the lowest revenue forecast at $1,498,952,340 and the highest revenue forecast at $1,498,952,340.